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Abstract
A central goal of cancer biology is to understand how cells from this family of genetic diseases undergo specific
morphological and physiological changes and regress to a de-regulated state of the cell cycle. The fact that tumors are
unable to perform most of the specific functions of the original tissue led us to hypothesize that the degree of specialization
of the transcriptome of cancerous tissues must be less than their normal counterparts. With the aid of information theory
tools, we analyzed four datasets derived from transcriptomes of normal and tumor tissues to quantitatively test the
hypothesis that cancer reduces transcriptome specialization. Here, we show that the transcriptional specialization of a
tumor is significantly less than the corresponding normal tissue and comparable with the specialization of dedifferentiated
embryonic stem cells. Furthermore, we demonstrate that the drop in specialization in cancerous tissues is largely due to a
decrease in expression of genes that are highly specific to the normal organ. This approach gives us a better understanding
of carcinogenesis and offers new tools for the identification of genes that are highly influential in cancer progression.
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Introduction
Cancer is a complex family of acquired genetic diseases in which
a single cell clone and its progeny accumulate heritable changes
that cause a malignant phenotype of deregulated cell growth and
differentiation [1]. Numerous studies have been performed to
better understand the alterations that occur in the transcription
profile during the progression of cancer [2]. These experiments
have been carried out by directly counting the tags of expressed
genes using serial analysis of gene expression (SAGE) [3],
expressed sequence tags (ESTs) [4], and other counting strategies,
or by indirectly measuring the levels of transcription using DNA
microarrays [5]. In many cases, these experiments have detected
genes that are preferentially expressed in a cancer tumor and can
serve as molecular markers of malignancy. In addition, they can
also detect significant alterations in the transcription level of sets of
genes that participate in complex signaling networks. Changes in
these networks represent distortions of the pathways that regulate
the physiology of normal cells [6].
Cancer cells lose the ability to perform the normal functions of
the original tissue, and at the same time, gain characteristics that
allow them to survive as an independent and frequently invasive
tumor. As cell lines evolve from a normal to a cancerous state,
mutations drive an increase in genetic diversity [7]. This process
occurs in parallel with the selection of phenotypes and genotypes
that permit the pre-cancerous cells to thrive in their microenvi-
ronment [8]. Tumor cells often lack the differentiation that is
present in the normal tissue that they originate from. Since the
mid-19
th century, this fact has lead pathologists to suggest that
tumors arise from embryo-like cells [9]. Given that cancer must
arise from a cell that has the potential to divide, two nonexclusive
hypotheses of the cellular origin of tumors have historically been
proposed. The first hypothesis states that malignancy arises from
stem cells due to maturation arrest; the second states that cancer
arises from the dedifferentiation of mature cells [10]. More
recently, however, the concept of ‘‘cancer stem cells’’, or rare cells
with a limitless potential for self-renewal, has gained acceptance as
a subpopulation of cells that drives tumorigenesis. This hypothesis
is based on findings that have shown that in some cases, only a
subset of the cells within a tumor have unlimited proliferative
potential [11]. However, this hypothesis remains controversial,
since the growth of certain malignant tumors is driven by a
substantial percentage of tumor cells that are not cancer stem cells
(greater than 10%) [12]. Regardless, there is clear evidence that
the undifferentiated phenotype of many tumor cells resembles the
phenotype of undifferentiated normal cells, such as embryonic
stem cells. Moreover, the study of gene expression in cancer
tumors has revealed that poorly differentiated tumors show
preferential overexpression of genes normally enriched in
embryonic stem cells, supporting the possibility that these genes
contribute to the stem cell-like phenotypes shown by many tumors
[13].
Previously, we described the development of indexes based on
Shannon’s information theory to measure transcriptome diversity,
specialization, and gene specificity of normal organs and tissues
[14]. In that study, we obtained an index of gene specificity, Si,
which has a value of zero for genes that are equally expressed in all
tissues and has a defined maximum value when a gene is expressed
in only one tissue. Transcriptome specialization, dj, therefore, is
defined as the average gene specificity expressed in the
transcriptome (see Materials and Methods). In general, a tissue is
more specialized if specific genes are highly expressed in it. We
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diversity and specialization that is related to their functionality. In
this study, we applied information theory tools to compare the
transcriptome diversity and specialization of cancerous tumors vs.
their normal counterparts. We show that the specialization of
cancer tissues generally diminishes when compared with their
normal counterparts, which is mainly due to the decrease in
expression of highly specific genes.
Results
We hypothesized that the morphological and functional changes
that occur during cancer progression would lead to substantial
changes in the cancer transcriptome, including a reduction in
specialization, when compared to that of analogous normal tissues.
To test this hypothesis in a broad framework, we selected three
collections of gene tags and one microarray experiment. Datasets
A and B are selected collections of cDNA libraries from the
‘‘Cancer Genome Anatomy Project’’ [15] for human and mouse
tissues, respectively. Dataset C consists of SAGE libraries from
normal human and tumor tissues obtained from the ‘‘Human
Transcriptome Map’’ project [16] and dataset D is a microarray
study of human tissues in normal and pre-cancerous states that
were paired by patient [17]. Datasets A and B incorporate five
embryonic stem cell (ESC) and one hematopoietic stem cell (HSC)
libraries and were included in the analysis based on their degree of
dedifferentiation. These datasets were subjected to the analysis of
information properties of the transcriptome as previously de-
scribed [14]. In the counting tags datasets, we assessed the
statistical significance of the differences in specialization. In each
case, we obtained the specificity (Si) and Target Specificity (TSij) for
the genes studied in the datasets, which allowed for the selection of
putative overexpressed genes in cancer or normal tissues as well as
the discrimination of genes preferentially expressed in a given
condition.
Evaluating transcriptome specialization in normal and
cancerous tissues
The analysis of datasets A and B for estimating the transcriptome
diversity (Hj,) and specialization (dj) indexes were done at three
levels of cDNA library grouping with the following designation:
individual cDNA libraries were defined as ‘‘ungrouped’’; assembled
cDNA libraries originating from the same kind of organ and tissue
state (normal or cancer) were defined as ‘‘grouped’’; and a further
clustering of the cDNA libraries that only considered the tissue state
and not the organ of origin were defined as ‘‘complete grouping’’
(see Materials and Methods). Hj measured the variability of the
distributions of transcripts and dj assessed the average specificity of
the genes expressed in the transcriptome. Visualization of the
positions of the transcriptomes in the (Hj, dj) coordinates allowed us
to effectively evaluate the relative differences in these significant
parameters. Results for the ungrouped analysis, dataset D analysis,
tables of confidence intervals for the relevant parameters, and
dissection of the differences in transcriptome specialization are
discussed in Supporting Text S1.
Figure 1 presents scatter plots for the levels of transcriptome
diversity, Hj, and specialization, dj, at the grouped level for datasets
A and B. When comparing 12 pairs of human analogous tissues,
11 cancerous tissues had significantly less specialization than their
normal counterparts, with eye cancer being the only tissue that
had an estimated specialization that was greater that its normal
counterpart (Figure 1A, Table S4, and Supporting Text S1).
However, after further analysis, we concluded that the eye tissue
sample is most likely distorted due to the smaller sample size of the
normal eye library (10,679 tags) compared to the cancerous eye
Figure 1. Scatter plot of Hj (Diversity) and dj (Specialization) in transcriptomes of normal tissues (blue), cancerous tissues (red), and
stem cells (black). Comparable data sets are linked by a discontinuous line. A - Human data from 53 libraries of 13 distinct tissues with a total of
671,197 tags for 28,087 genes; grouped analyses. B - Mouse data from 29 libraries of 5 distinct tissues and with a total of 541,453 expressed tags for
25,044 distinct genes; grouped analyses. Data for A and B are from the ‘‘Cancer Genome Anatomy Project’’ (http://cgap.nci.nih.gov/). Approximate
95% confidence intervals for diversity and specialization are plotted as continuous colored lines. See Supporting Text S1 as well as Figure S1, Figure
S2, Figure S3, Figure S4, Figure S5 and Figure S6 that illustrate individual comparisons and details.
doi:10.1371/journal.pone.0010398.g001
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prevented the correct estimation of eye-specific genes in the
normal library. All changes in specialization of the transcriptomes
are statistically significant (Table S4 and Table S5; P,0.01).
Figure 1A also shows that transcriptome diversity, measured by Hj,
increased in the cancerous states of all tissues, with the exception of
testis and placenta. The increase in Hj indicates a more even
distribution of the transcription levels of expressed genes, which is
most likely due to a decrease in the expression of genes prevalent
in the normal tissues. As shown in Figure 1A, we observed that the
specialization of the grouped ESC libraries is at the same level as
the majority of the cancer tissues. This is in agreement with the
low morphological specialization of ESCs.
In order to assess the drop in specialization of the cancerous
tissues, we compared the average specificity of genes that were
over-expressed in normal tissues to that in cancerous tissues. In
general, we found that there was a significantly greater average
specificity of genes over-expressed in normal tissues, suggesting
that the decrease in specialization was due to the reduction or
elimination of the expression of highly specialized genes in normal
tissues during carcinogenesis (see Table S11 and Figure S11). We
also analyzed the ten most influential genes that caused the
reduction in specialization in all eleven tissues of dataset A. For
each tissue, we found examples of organ-specific genes that were
switched off in the corresponding cancer tissue, including
Chondroadherin (CHAD) in bone, Uromodulin (UMOD) in
kidney, the acid phosphatase prostate specific (ACPP) gene in the
prostate, and a gene for the spermatogenesis-associated protein in
the testis (Table S12).
To confirm our hypothesis that specialization decreases in
cancerous tissues, we examined a completely independent model
of mouse tissues (dataset B). In this analysis, all of the normal
tissues showed significantly greater specialization than the
corresponding cancerous tissues (Figure 1B, Table S6 and Table
S7; P,0.01). Dataset B also included a library of HSCs obtained
from bone marrow. These cells showed a level of specialization
comparable with normal lung and skin even when undifferentiated
(Figure 1B). In four of the five organs studied in dataset B, the
average specificity of the genes that were over-expressed in normal
tissues was significantly greater than the corresponding value for
cancerous tissues, with the exception of the mammary gland
(Table S11). However, genes related to milk production, which
were within the most influential genes of the mammary gland and
have a high specificity of expression in this tissue (Table S13 and
Table S14), showed an extreme drop in expression in the
cancerous tissue. These results explain the general drop in
specialization seen in the mammary gland. In addition, the scatter
plots of gene frequency change between normal and cancerous
tissues vs. specialization showed a prevalence of highly specific,
over-expressed genes in normal tissues from the five organs studied
(Figure S12). We conclude that highly specific genes that have
diminished expression in the cancerous tissues drive the drop in
specialization, similar to that seen in dataset A.
The data from the ‘‘Human Transcriptome Map’’ (dataset C)
consist of a collection of SAGE gene tags that belong to
heterogeneous normal and tumor tissues that are grouped by
chromosome. We disregarded the obvious differences in transcrip-
tion profiles between distinct organs and only tested the hypothesis
that specialization diminishes in the tumor transcriptomes. It is
worth noting that in contrast to the analyses of datasets A and B,
where gene specificity was estimated for the combination of tissue
and condition, in dataset C the specificity is estimated only with
regard to the state of the tissue (normal vs. tumor) and disregards
the tissue of origin. Therefore, gene specificity in this dataset only
refers to normal or tumor tissues and implies that a much lower
estimated specialization would be observed. A large and significant
change in transcriptome specialization between the normal and
tumor tissues was seen for all chromosomes (Figure 2, Figure S7,
Figure S8, Figure S9 Figure S10, Table S9, and Supporting Text
S1), with the exception of chromosome Y, for which the difference
is not significant. Most of the differences that are significant (23 out
of 24) are in the expected direction and have less specialization in
the tumor transcriptomes. One exception to this was chromosome
18, for which the change in specialization is in the opposite
direction (see Supporting Text S1). However, the analysis of all loci
together (Figure 2 and Table S9) strongly supports the hypothesis
that cancer reduces specialization of the tissues.
In our previous study, we showed that the estimated rank of
variation of diversity and specialization in the human transcrip-
tome is much smaller when using microarrays than when counting
gene tags [14]. This is due to the relatively narrower dynamic
range of microarrays compared with tag counting strategies [18],
which distorts both high and low expressed genes. Despite these
shortcomings, the analysis of normal (TDLUs) and precancerous
(HELUs) tissues paired by patient (dataset D) showed a large drop
in specialization in precancerous tissues in seven of the eight cases
studied (Figure S13).
Genes detected only in cancer
The information theory approach for studying the transcrip-
tome has the advantage of allowing an estimation of the degree of
global gene specificity, Si, of each gene studied, as well as its target
specificity, TSij, a parameter that measures the specificity of a
given gene for a selected transcriptome (see Mathematical
Addendum in Supporting Text S1). These tools permit the easy
selection of genes that are preferentially expressed in cancer tissues
and therefore have the potential to serve as molecular markers of
malignancy. In addition, these indexes may aid in identifying
genes that are specific to a particular kind of cancer or genes that
are not significantly altered during the development of cancer and
therefore can serve as marker controls when measuring genes of
varying expression. It is important to note that when a gene in a
particular dataset is detected in only cancer tissues, it cannot be
inferred to be exclusively in cancer, since it could also be present in
normal tissues at undetectable levels. However, genes with high
levels of expression that are only found in cancer tissues are good
candidates for being significantly up-regulated in cancer.
To identify genes that are differentially expressed in cancer
tissues, we determined gene specificity (Si) and target specificity (TSij)
in dataset A using the complete grouping analysis. Table 1 shows
examples of genes represented in cancer tissues at the highest
proportion of expression level (greater than 1 in 10,000) and absent
from all normal tissues. These genes were only detected in the
cancer tissues, with a number of tags (ranging from 54 to 535) in
cancer tissues and no tags in normal tissues (maximum Si in the
analysis). To statistically validate the upregulated frequency of these
genes, we applied the Fisher exact test [19] with the Bonferroni
correction for multiple testing [20] (see Methods). Table 2 presents
genes that were detected in only one type of cancer. The
identification of these kinds of genes was possible (trough Si and
TSij) due to the inclusion of various types of cancer tissues in the
analysis. Table S10 shows examples of genes exclusively expressed at
relatively high rate in tumor tissues in the analysis of dataset C.
Discussion
The use of information theory tools to quantitatively assess
changes in steady state transcript abundances allowed us to
Cancer Transcriptomes
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frequency (.0.0001).
Gene Symbol Gene Description Frequency pij Tissues P-value
SILV Silver homolog (mouse) 0.00109391 3 ,2.2e–16
DHRS2 Dehydrogenase/reductase (SDR family) member 2 0.00024536 4 5.838e–13
SOX10 SRY (sex determining region Y)-box 10 0.00023105 2 3.732e–12
TRAF7 TNF receptor-associated factor 7 0.00022083 10 9.017e–12
C10orf2 Chromosome 10 open reading frame 2 (Twinkle) 0.00020038 8 1.467e–10
PRPS1 Phosphoribosyl pyrophosphate synthetase 1 0.00016971 10 5.846e–09
MLANA Melan-A 0.00015949 1 1.311e–08
AIPL1 Aryl hydrocarbon receptor interacting protein-like 1 0.00015949 2 1.311e–08
MAGEA6 Melanoma antigen family A, 6 0.00015949 5 1.311e–08
KLHL21 Kelch-like 21 (Drosophila) 0.00014517 9 8.442e–08
GNB3 Guanine nucleotide binding protein (G protein), beta polypeptide 3 0.00014313 2 8.137e–08
KIFC1 Kinesin family member C1 0.00014108 10 1.322e–07
S100B S100 calcium binding protein B 0.00013904 2 1.287e–07
CDT1 Chromatin licensing and DNA replication factor 1 0.00013086 11 3.23e–07
ZWINT ZW10 interactor antisense 0.00012677 10 8.912e–07
XAB2 XPA binding protein 2 0.00011655 9 1.997e–06
SLC45A2 Solute carrier family 45, member 2 0.00011041 2 5.299e–06
Frequency pij – Relative average frequency of expression in cancer tissues. Tissues – Number of cancerous tissues where the gene was expressed in the 12 tissues
studied in dataset A. P-value for the Fisher’s Exact Test for the frequency of expression of the gene in normal vs. cancer tissues; significant at an a<0.05 experiment-wise
confidence level by Bonferroni correction.
doi:10.1371/journal.pone.0010398.t001
Figure 2. Scatter plot of Hj (Diversity) and dj (Specialization) in transcriptomes of normal (blue) and tumor (red) tissues in dataset C.
Human expression data are from the ‘‘Human Transcriptome Map’’ project (http://bioinfo.amc.uva.nl/HTMseq/controller), datasets ‘‘All tissues
normal’’ and ‘‘All tissues tumor’’. Data consist of 18,609,073 tags for a total of 62,916 loci by chromosome. See Figure S7, Figure S8, Figure S9 and
Figure S10 that amplify the boxes of this figure presenting the 95% confidence intervals for the estimates.
doi:10.1371/journal.pone.0010398.g002
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tissues have less transcriptome specialization than their normal
counterparts. The results obtained from these analyses showed
that specialization of the cancer transcriptome decreased when
compared to the normal tissue equivalent. The decrease in
transcriptome specialization was due mainly to a reduction in the
expression level of genes that are tissue-specific and usually
expressed at high levels in normal tissue (see Supporting Text S1
and Table S11, Table S12, Table S13, Table S14, Table S15 and
Table S16). These results are in agreement with the observation
that tumors often show morphologically dedifferentiated cell types
in a manner similar to that observed in stem cells [21]. In addition,
molecular evidence has shown that poorly differentiated cancer
tumors overexpress genes that are enriched in embryonic stem
cells [13]. It is not completely clear whether cancer initiates by a
process of de-regulation of organ stem cells or by a de-novo
dedifferentiation of organ cells driven by the mutations that arise
during the development of the tumor [7].
All high throughput transcriptome studies that used either
counting tag strategies or microarrays only measured relative
changes in transcription levels. This approach makes the
universally accepted assumption that all cells have the same
absolute transcriptional activity. However, this assumption lacks
experimental validation, especially in the case of cancer cells. The
method used in this study measured relative levels of gene
expression (the set of pij) to assess gene specificity, transcriptome
diversity, and specialization. Therefore, we cannot rule out the
possibility that all of the genes could have a higher absolute
expression level in cancer than in normal tissues. Nevertheless, a
general increase in transcription in cancerous cells would not have
a major impact in the transcriptome specialization or in the
specificity of gene expression.
Transcriptome specialization, di, is measured exclusively in the
context of the organs or tissues included in the analysis and reflects
the organ or tissue bias towards the expression of specific genes.
To estimate the ‘‘true’’ specialization of a tissue, all distinct cell
types of a given organ must be included separately in the analysis.
This was not fulfilled in the analysis performed here due to
limitations in the data used in this study. A second factor that
affects the estimation of specialization is the sample size, or more
specifically, the number of gene tags employed. Highly specific
genes tend to be expressed in a small subset of the cells that form
an organ and thus have a high probability of not having any gene
tags and not being present if the sample is relatively small. As a
result, specialization tends to be underestimated in small sample
sizes. In the case of dataset A, the total number of tags was
620,696, with 131,623 (21%) tags corresponding to normal tissues
and the remaining 489,073 (79%) tags corresponding to cancerous
tissues. Therefore, the potential for underestimation of specializa-
tion was higher for normal tissues than for cancerous tissues.
Nevertheless, Figure 1A shows strong evidence of less specializa-
tion in the cancerous tissues. This was observed in datasets B and
C as well.
Human organs are comprised of different numbers and types of
cells and therefore have distinct levels of complexity. A more
complex organ will have a greater number of distinct cell types,
and as a result, the estimation of its diversity and specialization will
be less precise and require a larger sample size for accuracy. In
contrast, tumors are formed by a small number of distinct cell
types and the estimation of its diversity and specialization will be
more precise with a given sample size. This is evident by the size of
the confidence intervals for each point in Figure 1 (also see Figure
S1, Figure S2, Figure S3, Figure S4, Figure S5 and Figure S6). In
both cases (datasets A and B), the size of the confidence intervals is
larger for the normal tissues analyzed than for their cancerous
counterparts. Nevertheless, the differences in specialization
between normal and cancerous tissues are several confidence
intervals apart, demonstrating that the conclusions are statistically
robust (Table S4, Table S5, Table S6, Table S7 and Table S8).
It is well known that tumor cells are often undifferentiated and
resemble embryonic stem cells [9]. To compare the level of
specialization of cancer tissues with that of ESCs, we included five
libraries of ESCs in dataset A and analyzed them individually
(Figure S1) or as a group (Figure 1A). The position of the ESC in
Figure 1 and Figure S1 corroborates that the level of specialization
of stem cells is comparable to the majority of the cancer tissues
analysed. These data confirm the correlation between the
phenotypic dedifferentiation and the drop in specialization in
both ESCs and cancer cells. Unfortunately, data showing the
degree of dedifferentiation in the distinct tumors analysed in
datasets A, B, and C were not present in the databases, and
therefore we could not infer whether there is a relationship
between the degree of dedifferentiation of the tumor and its drop
in specialization. However, we hypothesize that this relationship
probably exists, since the degree of dedifferentiation of the tumor
appears to correlate with the expression of the sets of genes that
are enriched in ESCs [13].
We analyzed a library of HSCs as part of dataset B. This library
was made from FACS-purified, hematopoietic stem cells obtained
from bone marrow and represents cells that can differentiate into
myelomonocytic cells, B cells, or T cells. In contrast with the ESCs
of Figure 1, these cells originated from a specialized adult organ.
As shown in Figure 1B, HSCs have a level of estimated
specialization comparable to that of normal lung and higher than
Table 2. Examples of genes highly expressed in only one type of cancer in dataset A.
Organ Gen symbol Gen description pij P-value
Eye OTX2 Orthodenticle homeobox 2 0.00074 0.00131448
Liver ASGR2 Asialoglycoprotein receptor 2 0.00063 0.01024596
Lung T T, brachyury homolog (mouse) 0.00050 0.00692187
Lymph C4orf7 Chromosome 4 open reading frame 7 0.00065 0.01260259
Limphr IL9R Interleukin 9 receptor 0.00052 0.001396
Placenta DNMT3L DNA (cytosine-5-)-methyltransferase 3-like 0.00084 4.0955e–07
Skin MLANA Melan-A 0.00066 0.00964147
Frequency pij – Relative average frequency of expression in cancer tissues. P-value for the Fisher’s Exact Test for the frequency of expression of the gene in the normal
vs. cancer tissues
doi:10.1371/journal.pone.0010398.t002
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cell types can present a relatively high specialization of the
transcriptome. Our conclusion is also supported by the tran-
scriptome analysis of normal lymphatic tissues (Lymph and
Lymphr; Figure 1A).
We propose that the fitness of a pre-cancerous cell, in the
context of a tumor, will be increased if the genes related to the
original function of the parental tissue are switched off, because
this highly expressed and specific set of genes represents a high cost
in energy and resources that would be disadvantageous in the
context of the tumor. Our hypothesis suggests that if the
expression of these highly expressed and specific genes is reduced
or turned off, then a decrease in tissue specialization should be
observed. Dissecting the reduction in specialization through
analysis of the individual genetic components will provide a better
understanding of carcinogenesis. Moreover, if the drop in
expression of at least some of these genes precedes morphological
changes in the pre-cancerous cells, the drop could be exploited for
diagnostic proposes. Our hypothesis is not contradicted by the
observation of dedifferentiation in cancer tissues, but rather
parallels this finding: tissues with a greater dedifferentiated
phenotype will express a less specialized transcriptome.
The analysis in dataset C was performed on loci that were
grouped by chromosomes from a heterogeneous mixture of tissues
classified only as ‘‘normal’’ or ‘‘tumor’’. Therefore, the specificity
of the loci is only estimated with regard to this criterion and not
with regard to the organ of origin as in datasets A and B. As a
consequence, the specialization estimated for the ‘‘normal’’ and
‘‘tumor’’ tissues is much smaller than the rank of specialization
estimated when the organ of origin is taken into account (compare
figures 1 and 2). Despite smaller differences in specialization
between normal and cancerous tissues in dataset C, the data are
statistically significant for all chromosomes (except for chromo-
some Y) and all cases, except for chromosome 18, indicate that a
drop in specialization occurs in tumors (Table S8). Interestingly,
chromosome 18 contains several tumor suppressor genes including
DDC, DPC4, and JV18-1/MADR2 [22], and therefore the high
expression of these genes could drive the observed increase in
specialization (see Table S15). Taken together, these data serve an
independent confirmation of the hypothesis that transcriptome
specialization diminishes in tumors. We predict that enhanced
understanding of the mechanisms responsible for the drop in
specialization that occurs in tumors through better characteriza-
tion of cancer transcriptome profiles will lead to the development
of new molecular diagnosis tools and intervention techniques.
From the analysis of grouped normal and cancerous tissues in
dataset A (‘‘complete grouping’’; see Methods) we detected 14,573
genes (52%) out of a total of 28,087 genes that were represented in
either normal or cancerous tissues only (estimated gene specificity
Si=1). Of these genes with maximum specificity, 6,220 (43%) were
detected exclusively in cancer and the remaining 8,353 (57%) were
detected exclusively in normal tissues. Our observations that
particular genes were found in only one specific group (normal or
cancerous tissues) were dependent upon the sample size and
therefore required statistical analyses to determine the significance.
The Fisher’s exact test with Bonferroni correction (see Methods)
concluded that only 17 of the genes that were exclusively detected
in cancerous tissues were significantly upregulated. These genes
are presented in Table 1. Table S17 presents the Gene Ontology
classifications for the genes presented in Table 1.
If information theory indexes are effective in identifying genes
upregulated in cancer, they should also detect genes that have
previously been reported to be associated with cancer. This was
indeed the case, as the list of genes exclusively detected in cancer
(Table 1), including TRAF7, PRPS1, CDT1, and ZWINT, were
previously reported as cancer marker genes [23,24,25,26]. More
importantly, this quantitative approach identifies genes potentially
involved in cancer that have not been previously identified, such as
KLHL21, KIFC1, and XAB2 (Table 1). A description of the genes
listed in Table 1 is presented in Supporting Text S1.
The genes listed in Table 2 were found to be present in only one
type of cancer at significantly high levels of expression (grouped
analysis, dataset A) and exemplify the rich possibilities of data-
mining using specificity (Si) and target specificity (TSij) of gene
expression. Among these genes, we found examples of cancer
markers (MLANA) (also reported in Table 1), a recently described
oncogene (OTX2) [27], and a gene used as a predictor of
circulating tumor cells (ASGR2) [28]. In lung cancer, we identified
a gene (T, the human T brachyury homologue) that has been
reported to be epigenetically silenced in non-small-cell lung cancer
[29], and in lymph cancer, we found a gene (C4orf7) that was
previously reported to have significantly high expression in lymph
node metastases [30]. Table S18 presents the Gene Ontology
classifications for the genes presented in Table 2.
The analysis performed here did not take into account the
mRNA splicing that forms distinct proteins, since the tags
employed were only annotated at the gene level in the datasets.
Further investigation is needed to assess the effect of splicing
deregulation in cancer over the transcriptome diversity and
specialization.
In the future, a more detailed functional analysis of genes with
altered expression in cancer will provide a better understanding of
their role in this dynamic process.
General conclusions
Our present data advance the current hypothesis that cancer
diminishes the specialization of affected tissues. This suggests that
although cancer tissues gain specialized functions in cell cycle
control, angiogenesis, and metastasis, they concomitantly exhibit a
loss of specialization and deregulation of sets of genes with tissue-
specific functions.
The application of gene specificity and target specificity
provides a powerful, practical tool for data mining of the
numerous studies that have already compared gene expression
in normal and cancerous tissues. We have shown how this method
has the capability to recover not only genes well known to be
associated with cancer, but also less understood genes that are
highly expressed and up-regulated in neoplasia. This approach will
help us understand the process of tumor development and
hopefully provide new possibilities for intervention with drugs
and genomic medicine. These same tools can be used to identify
genes that are down-regulated in cancer or control genes that
remain constant during the process. In addition, these information
tools can be easily adapted to existing web pages that show
transcription results from counting gene tag strategies as well as
microarrays experiments.
Materials and Methods
Datasets
Dataset A – Human expression data from the ‘‘Cancer
Genome Anatomy Project’’. The data are from the ‘‘Cancer
Genome Anatomy Project’’ (http://cgap.nci.nih.gov/) [15] and
were downloaded from the site ftp://ftp1.nci.nih.gov/pub/
CGAP/ in July 2008. The data consist of diverse libraries of
cDNA with expression profiles (specific genes identified and the
number of tags found) for distinct human organs under diverse
conditions. The data were downloaded and placed into a MySQL
Cancer Transcriptomes
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applied in order to select the human data to be analyzed: 1) Only
non-normalized libraries that reflected the true gene expression
were considered; 2) the libraries had to contain at least 5000 gene
tags; 3) only libraries derived from a single organ or tissue were
considered (libraries from mixed organs and cell lines were not
allowed); and 4) each library had to have a comparable library
from normal tissue to be considered. In addition to the cancer
libraries and their normal counterparts, we included five libraries
of ESCs that were considered suitable for comparison of the
specialization of non-differentiated cell types. These libraries also
fulfilled the criteria (1–3) described above. Dataset A included 53
libraries from 13 distinct tissues that had a total of 671,197 gene
tags for 28,087 human genes that fulfilled the above criteria. Table
S1 presents the main characteristics of the libraries.
Table S1 indicates that in two cases (placenta and testis), two
libraries from normal tissues of the same organ were selected. In
various cases more than one library from a neoplasia were selected
from the same tissue. Table S1 also shows that there are highly
variable numbers of gene tags in each library, ranging from 5,003
in the testis library to 37,803 in the Skin library. On average, the
libraries have 12,931 gene tags. The total number of distinct
human genes represented in at least one of the libraries was
28,087.
Dataset B – Mouse expression data from the ‘‘Cancer
Genome Anatomy Project’’. Dataset B represents mouse data
downloaded from the ‘‘Cancer Genome Anatomy Project’’ from
the same site and the same date. The selection of libraries from this
set followed the same criteria set for dataset A. Dataset B also
included a library of hematopoietic stem cells (HSC). Dataset B
was comprised of 30 libraries from 6 distinct tissues with a total of
541,453 expressed gene tags for 25,044 distinct mouse genes that
fulfilled the selection conditions described above. Table S2
presents the main characteristics of the libraries.
Dataset C – Human normal and tumor tissues from the
‘‘Human Transcriptome Map’’ (HTM). The HTM project
[Caron, 2001 #111] (http://bioinfo.amc.uva.nl/HTMseq/controller)
integrates mapping data with genome-wide messenger RNA
expression profiles as provided by serial analysis of gene expression
(SAGE). The data consist of map and expression information and were
downloaded by chromosome from the site in July 2008. For this study,
we downloaded the dataset titled ‘‘All tissues normal’’ that contained
5,747,834 tags from normal human tissues and the dataset titled ‘‘All
tissues tumor’’ that contained 12,861,239 tags from diverse cancer
tumors. The combined datasets represented a total of 62,916 loci
distributed along the human genome. The data were separately
downloaded for each of the 24 chromosomes (Chromosomes 1 to 22,
X, and Y) in files normalized to rates of 10,000 tags. The files were
included in a relational MySQL database and re-converted to the
original number of expressed tagsi ne a c hl i b r a r y .T h ed a t aw e r e
then placed in one file for each chromosome and a master file
containing the data for all chromosomes. Table S3 presents the
number of tags per chromosome in each of the two libraries (normal
and tumor).
Dataset D – Human microarray data of normal and
precancerous states in breast tissue. The dataset D
consisted of a set of 16 microarrays from paired samples of
normal, terminal duct lobular units (TDLUs; 8 samples) and
hyperplastic, enlarged lobular units (HELUs; 8 samples) from
RNA samples obtained by microdissection [Lee, 2007 #108]. The
data were downloaded from the GEO database at the NCBI
(GEO accession GDS2739; http://www.ncbi.nlm.nih.gov/) in
July 2008. This dataset has expression information for 34,702
human genes in each of the 16 arrays.
Information theory and statistical analyses
If we consider the relative frequencies of transcription pij for the
i-th gene (i=1, 2, …, g) in the j-th tissue or transcriptome (j=1, 2,
…, t), then the diversity of the transcriptome of each tissue can be
quantified by an adaptation of Shannon’s entropy formula,
Hj~{
X g
i~1
pijlog2 pij
  
:
Hj will vary from zero when only one gene is transcribed up to
log2(g) where all g genes are transcribed at the same frequency: 1/g.
If we consider the average frequency of the i-th gene among tissues,
say,
pi~
1
t
X t
j~1
pij
we can define gene specificity as
Si~
1
t
X t
j~1
pij
pi
log2
pij
pi
 !
:
Si will attain a value of zero if the gene is transcribed at the same
frequency in all tissues and a maximum value of log2(t) if the gene is
exclusively expressed in a single tissue. Tissue specialization is then
measured, for the j-th tissue, as the average gene specificity, say
dj~
X g
i~1
pijSi:
These formulas were previously described [14]. For further details
see Mathematical Addendum in Supporting Text S1.
To apply the analysis of information parameters of the
transcriptome, estimating its diversity, Hj, and specialization, dj,
as well as the gene specificities, Si, and target specificities, TSij,i ti s
necessary to have estimates, pij, of the relative frequency of
expression of the i-th gene in the j-th transcriptome, where i=1, 2,
…, g, the total number of genes, and j=1, 2, …, t, the total
number of transcriptomes (tissues) studied [14] (see also Mathe-
matical Addendum in Supporting Text S1). For datasets A, B, and
C, which are the product of counting strategies, the values of pij
were obtained by dividing the number of tags for gene i in the j
transcriptome (library or set of libraries) by the total number of
tags obtained in the transcriptome j. For microarray data (dataset
D; see Supporting Text S1), the pij were obtained by dividing the
normalized signal obtained for gene i in the j transcriptome by the
sum of normalized signals in the transcriptome j (microarray slide
j). Using the matrices, {pij}, the analysis was performed by using
the statistical environment R [31], by use of a set of functions
developed to such effect.
To obtain confidence intervals for the information parameters
in the datasets A, B,a n dC, we applied the bootstrap procedure
[32]. This assumed a multinomial distribution for the number of
tags in the transcriptome, and obtained B=2000 bootstrap
replicates, which are samples from the multinomial distribution
where the total number of tags in the transcriptome, nj,a n dt h e
observed relative frequencies, {pij}, are assumed as parametric
Cancer Transcriptomes
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number of tags representing each gene in a transcriptome
a p p e a r sr e a s o n a b l ee v e ni fi tm o s tl i k e l yu n d e r e s t i m a t e st h er e a l
biological variation and possible dependencies in sets of genes
present in the transcriptome. Having obtained the set of
B=2000 bootstrap replicates of each parameter, we applied
the Bootstrap Percentile Method [32] at 95% confidence level to
obtain the confidence intervals plotted in the figures presented
(Figure 1A, Figure 1B, and supporting Figure S1, Figure S2,
Figure S3, Figure S4, Figure S5, Figure S6, Figure S7, Figure
S8, Figure S9 and Figure S10).
Using the same bootstrap approach, we obtained approximated
99% confidence intervals for the true differences between the
specialization of pairs of transcriptomes, for example Dmn=dm2dn,
where m and n are the transcriptomes of interest (normal and
cancer tissues), for which the hypothesis of equal specialization
(H0: Dmn=0) needed to be tested. The null hypothesis of identical
specialization was rejected when the approximated 99% confi-
dence interval did not include the value of 0. We also tested the
assumption of normality for the bootstrap estimates by means of
the Shapiro-Wilks test [33] (Table S4, Table S5, Table S6, Table
S7 and Table S8).
The estimation of confidence intervals and hypothesis testing
was not feasible for the microarray data (dataset D), since in that
case, the original data belonged to an unknown continuous
distribution, and the assumption of a given distribution is difficult
without having a very good estimate of the (unknown) variances
and covariances for the gene expression levels. The absence of true
replicates in these data (dataset D) made it impossible to obtain
confidence intervals for the parameters or to perform statistical
tests on the specialization differences.
Dataset Grouping
The analysis for datasets A and B were done at three levels of
grouping. First, the ‘‘ungrouped’’ analysis was performed by
considering each of the individual libraries (Table S1 for dataset
A and Table S2 for dataset B), with comparisons between the
levels of specialization being done between the normal and
cancerous states in libraries of the same tissue (Figure S1, Figure
S2, Figure S4, and Figure S5). The second level, designated here
as ‘‘grouped analysis’’, corresponds to grouping libraries that
were from the same tissue and state (normal or cancerous). This
was done by adding the tags for each gene in the corresponding
datasets. This is a valid procedure since the libraries are
independently obtained from the same organ in approximately
the same tissue state (normal or cancerous). In addition, the
variations that are disregarded correspond to biological differ-
ences between individuals from which the samples were obtained,
putative differences in methodology of sequencing, and random
variation. The third level of grouping, ‘‘complete grouping’’,
added tags from all distinct tissues in the same state (normal or
cancerous) to form only two groups: normal and cancerous states.
This ‘‘complete grouping’’ disregards or confounds the tran-
scriptome variation given by the different nature of the tissues,
but allows for the analysis of differences between cancerous and
normal tissues, which is the main source of this study (Figure S3
and Figure S6). This procedure is analogous to the collapse of
contingency tables routinely performed in the statistical analysis
of discrete data [19].
To evaluate the statistical significance of genes exclusively
detected in cancer in dataset A (Table 1) we used the Fisher’s exact
test [19] on the 262 contingency table produced by grouping the
tags belonging to the categories ‘‘normal’’ or ‘‘cancer’’ and ‘‘gene
I’’ or ‘‘gene no-I’’ for each one of the 6,220 genes found to be
exclusively detected in cancer. Given that we were performing
6,220 tests, the Bonferroni correction for multiple testing [20] was
applied by dividing the desired experimental-wise error Type I
(a=0.05) between the number of tests to be performed, for
example 0.05/6,220<7.5e–6. Only genes with P-value less than
7.5e–6 in the Fisher’s exact test are presented in Table 1. The
same procedure was performed to obtain the significance (P-value)
for the data of Table 2, except that in this case, no correction was
needed since only one gene was tested for each (independent) set of
tags in a given type of cancer.
For dataset C, which corresponds to human data for normal
and tumor tissues grouped by chromosome, an individual analysis
was performed for the loci in each chromosome followed by a
complete analysis for all loci together. This analysis was performed
on the non-normalized tags, since the information analysis
normalizes the data by taking the relative frequencies of expression
of each gene (pij). As in the cases of datasets A and B, a bootstrap
analysis was performed to obtain confidence intervals for the
parameters of interest and to test the differences in specialization
between normal and tumor tissues.
Supporting Information
Text S1 Includes supporting text, supporting methods, support-
ing discussion, mathematical addendum, functions source code
and supporting references.
Found at: doi:10.1371/journal.pone.0010398.s001 (0.88 MB
PDF)
Figure S1 Estimated values of Hj (diversity) and dj (specializa-
tion) in each one of the libraries of dataset A, ungrouped analysis.
Found at: doi:10.1371/journal.pone.0010398.s002 (0.22 MB
PDF)
Figure S2 Estimated values of Hj (diversity) and dj (specializa-
tion) in each one of the libraries of dataset A, non-grouped
analysis. One panel per organ.
Found at: doi:10.1371/journal.pone.0010398.s003 (0.03 MB
PDF)
Figure S3 Estimated values of Hj (diversity) and dj (specializa-
tion) in normal and cancerous transcriptomes obtained by
grouping all organs in dataset A.
Found at: doi:10.1371/journal.pone.0010398.s004 (0.05 MB
PDF)
Figure S4 Estimated values of Hj (diversity) and dj (specializa-
tion) in each one of the libraries of dataset B (mouse data), non-
grouped analysis.
Found at: doi:10.1371/journal.pone.0010398.s005 (0.07 MB
PDF)
Figure S5 Estimated values of Hj (diversity) and dj (specializa-
tion) in each one of the libraries of dataset B (mouse data), non-
grouped analysis. One panel per organ.
Found at: doi:10.1371/journal.pone.0010398.s006 (0.08 MB
PDF)
Figure S6 Estimated values of Hj (diversity) and dj (specializa-
tion) in normal and cancerous transcriptomes obtained by
grouping all organs in dataset B (mouse data).
Found at: doi:10.1371/journal.pone.0010398.s007 (0.05 MB
PDF)
Figure S7 Estimated values of Hj (diversity) and dj (specializa-
tion) in the chromosome Y (dataset C).
Found at: doi:10.1371/journal.pone.0010398.s008 (0.05 MB
PDF)
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tion) in chromosomes 21, 18, 13, 22, 20 and X (dataset C).
Found at: doi:10.1371/journal.pone.0010398.s009 (0.05 MB
PDF)
Figure S9 Estimated values of Hj (diversity) and dj (specializa-
tion) in chromosomes 14, 8, 15, 9, 10, 16, 4, 6, 7, 5, 11, 3, 12, 17,
19 and 2. Dataset C.
Found at: doi:10.1371/journal.pone.0010398.s010 (0.06 MB
PDF)
Figure S10 Estimated values of Hj (diversity) and dj (specializa-
tion) in chromosomes 1 and the set of all chromosomes taken
together. Dataset C.
Found at: doi:10.1371/journal.pone.0010398.s011 (0.05 MB
PDF)
Figure S11 Example of scatter plot for the differences in
expression in Dataset A (Human dataset).
Found at: doi:10.1371/journal.pone.0010398.s012 (0.36 MB
PDF)
Figure S12 Example of scatter plot for the differences in
expression in Dataset B (Mouse dataset).
Found at: doi:10.1371/journal.pone.0010398.s013 (0.38 MB
PDF)
Figure S13 Scatter plot of Hj (Diversity) and dj (Specialization)
in transcriptomes of normal (blue) and precancerous (red) tissues in
dataset D.
Found at: doi:10.1371/journal.pone.0010398.s014 (0.10 MB
PDF)
Table S1 Human libraries from the "Cancer Genome Anatomy
Project" selected for analysis (Dataset A).
Found at: doi:10.1371/journal.pone.0010398.s015 (0.07 MB
PDF)
Table S2 Mouse libraries from the "Cancer Genome Anatomy
Project" selected for analysis (Dataset B).
Found at: doi:10.1371/journal.pone.0010398.s016 (0.05 MB
PDF)
Table S3 Number of tags and loci per chromosome in dataset C
(Human normal and tumor tissues from the "Human Transcrip-
tome Map").
Found at: doi:10.1371/journal.pone.0010398.s017 (0.02 MB
PDF)
Table S4 Approximate 99% Confidence Intervals for the
difference between specializations in all pairs of comparable
tissues (normal versus cancer) in dataset A (grouped analysis).
Found at: doi:10.1371/journal.pone.0010398.s018 (0.02 MB
PDF)
Table S5 Approximate 99% Confidence Intervals for the
difference between specializations in all pairs of comparable
libraries (non-grouped analysis, dataset A).
Found at: doi:10.1371/journal.pone.0010398.s019 (0.03 MB
PDF)
Table S6 Approximate 99% Confidence Intervals for the
difference between specializations in all pairs of comparable
tissues (normal versus cancer) in the B dataset (mouse data);
grouped analysis.
Found at: doi:10.1371/journal.pone.0010398.s020 (0.01 MB
PDF)
Table S7 Approximate 99% Confidence Intervals for the
difference between specializations in all pairs of comparable
libraries in dataset B (mouse data); non-grouped analysis.
Found at: doi:10.1371/journal.pone.0010398.s021 (0.03 MB
PDF)
Table S8 Approximate 99% Confidence interval for the
differences in specialization between normal and tumor tissues in
chromosomes in the analysis of dataset C (Human Transcriptome
Map).
Found at: doi:10.1371/journal.pone.0010398.s022 (0.02 MB
PDF)
Table S9 Number of tags and loci per chromosome in dataset C
(Human normal and tumor tissues from the "Human Transcrip-
tome Map").
Found at: doi:10.1371/journal.pone.0010398.s023 (0.02 MB
PDF)
Table S10 Examples of genes exclusively expressed at relatively
high rate in tumor tissues in the analysis of dataset C (HTM).
Found at: doi:10.1371/journal.pone.0010398.s024 (0.02 MB
PDF)
Table S11 Statistical analyses of genes over expressed in normal
and cancer tissues in the human dataset A with regard to their
specificity and differences in frequency of expression.
Found at: doi:10.1371/journal.pone.0010398.s025 (0.08 MB
PDF)
Table S12 The ten genes with largest influence (See Eq. 8) in the
change of specialization of cancerous tissues per organ. Dataset A
(human dataset).
Found at: doi:10.1371/journal.pone.0010398.s026 (0.14 MB
PDF)
Table S13 Statistical analyses of genes over expressed in normal
and cancer tissues in the mouse dataset (B) with regard to their
specificity and differences in frequency of expression.
Found at: doi:10.1371/journal.pone.0010398.s027 (0.07 MB
PDF)
Table S14 The ten genes with largest influence (See Eq. 8) in the
change of specialization of cancerous tissues per organ. Dataset B
(mouse dataset).
Found at: doi:10.1371/journal.pone.0010398.s028 (0.10 MB
PDF)
Table S15 Statistical analyses of loci over expressed in normal
and tumor tissues in Chromosome 18 of dataset (C) with regard to
their specificity and differences in frequency of expression.
Found at: doi:10.1371/journal.pone.0010398.s029 (0.06 MB
PDF)
Table S16 The ten most influential loci in the increase of
specialization of tumors in Chromosome 18 (dataset C).
Found at: doi:10.1371/journal.pone.0010398.s030 (0.05 MB
PDF)
Table S17 Classifications by Gene Ontology of the genes
presented in Table 1.
Found at: doi:10.1371/journal.pone.0010398.s031 (0.05 MB
PDF)
Table S18 Classifications by Gene Ontology for the genes
presented in Table 2.
Found at: doi:10.1371/journal.pone.0010398.s032 (0.05 MB
PDF)
Acknowledgments
We are grateful to Lorenza Gonza ´lez-Mariscal and David Torrents for
critical comments to a previous version of the manuscript and to three
anonymous reviewers for useful criticism and suggestions.
Cancer Transcriptomes
PLoS ONE | www.plosone.org 9 May 2010 | Volume 5 | Issue 5 | e10398Author Contributions
Conceived and designed the experiments: OM MHRV. Performed the
experiments: OM. Analyzed the data: OM. Contributed reagents/
materials/analysis tools: MHRV LHE. Wrote the paper: OM LHE.
Designed the formula for Target Specificity (TS): MHRV.
References
1. Klausner RD (2002) The fabric of cancer cell biology–Weaving together the
strands. Cancer Cell 1: 3–10.
2. Mihich E, Feunteun J, Friend S (2002) Thirteenth Annual Pezcoller Symposium:
Focusing Analytical Tools on Complexity in Cancer. Cancer Res 62:
3883–3887.
3. Porter D, Polyak K (2003) Cancer target discovery using SAGE. Expert Opinion
on Therapeutic Targets 7: 759–769.
4. Brentani H, Caballero OL, Camargo AA, da Silva AM, da Silva WA, Jr., et al.
(2003) The generation and utilization of a cancer-oriented representation of the
human transcriptome by using expressed sequence tags. PNAS 100:
13418–13423.
5. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) Large-
scale meta-analysis of cancer microarray data identifies common transcriptional
profiles of neoplastic transformation and progression. Proceedings of the
National Academy of Sciences of the United States of America 101: 9309–9314.
6. Majeti R, Becker MW, Tian Q, Lee T-LM, Yan X, et al. (2009) Dysregulated
gene expression networks in human acute myelogenous leukemia stem cells.
Proceedings of the National Academy of Sciences: -.
7. Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, et al. (2006)
Genetic clonal diversity predicts progression to esophageal adenocarcinoma.
Nature Genetics 38: 468–473.
8. Gatenby RA, Gillies RJ (2008) A microenvironmental model of carcinogenesis.
Nat Rev Cancer 8: 56–61.
9. Sell S (2004) Stem cell origin of cancer and differentiation therapy. Crit Rev
Oncol Hematol 51: 1–28.
10. Sell S (1993) Cellular origin of cancer: dedifferentiation or stem cell maturation
arrest? Environ Health Perspect 101 Suppl 5: 15–26.
11. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and
cancer stem cells. Nature 414: 105–111.
12. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A (2007) Tumor growth need
not be driven by rare cancer stem cells. Science 317: 337.
13. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, et al. (2008) An
embryonic stem cell-like gene expression signature in poorly differentiated
aggressive human tumors. Nat Genet 40: 499–507.
14. Martı ´nez O, Reyes-Valde ´s H (2008) Defining diversity, specialization, and gene
specificity in transcriptomes through information theory. Proceedings of the
National Academy of Sciences 105: 9709–9714.
15. Riggins GJ, Strausberg RL (2001) Genome and genetic resources from the
Cancer Genome Anatomy Project. Hum Mol Genet 10: 663–667.
16. Caron H, Schaik Bv, Mee Mvd, Baas F, Riggins G, et al. (2001) The Human
Transcriptome Map: Clustering of Highly Expressed Genes in Chromosomal
Domains. Science 291: 1289–1292.
17. Lee S, Medina D, Tsimelzon A, Mohsin SK, Mao S, et al. (2007) Alterations of
Gene Expression in the Development of Early Hyperplastic Precursors of Breast
Cancer. Am J Pathol 171: 252–262.
18. t Hoen PAC, Ariyurek Y, Thygesen HH, Vreugdenhil E, Vossen RHAM, et al.
(2008) Deep sequencing-based expression analysis shows major advances in
robustness, resolution and inter-lab portability over five microarray platforms.
Nucl Acids Res 1: gkn705.
19. Everitt BS (1992) The Analysis of Contingency Tables: Chapman & Hall. pp
1–164.
20. Ewens WJ, Grant GR (2001) Statistical Methods in Bioinformatics: Springler.
476 p.
21. Beachy PA, Karhadkar SS, Berman DM (2004) Tissue repair and stem cell
renewal in carcinogenesis. Nature 432: 324–331.
22. Wodarz D, Komarova NL (2005) Computational biology of cancer: lecture
notes and mathematical modeling: World Scientific.
23. Obuse C, Iwasaki O, Kiyomitsu T, Goshima G, Toyoda Y, et al. (2004) A
conserved Mis12 centromere complex is linked to heterochromatic HP1 and
outer kinetochore protein Zwint-1. Nature Cell Biology 6: 1135–1141.
24. Reyes I, Tiwari R, Geliebter J, Reyes N (2007) DNA microarray analysis reveals
metastasis-associated genes in rat prostate cancer cell lines. Biome ´dica 27:
190–203.
25. Xouri G, Lygerou Z, Nishitani H, Pachnis V, Nurse P, et al. (2004) Cdt1 and
geminin are down-regulated upon cell cycle exit and are over-expressed in
cancer-derived cell lines. European Journal of Biochemistry 271: 3368–3378.
26. Xu L-G, Li L-Y, Shu H-B (2004) TRAF7 Potentiates MEKK3-induced AP1 and
CHOP Activation and Induces Apoptosis. J Biol Chem 279: 17278–17282.
27. Di C, Liao S, Adamson DC, Parrett TJ, Broderick DK, et al. (2005)
Identification of OTX2 as a Medulloblastoma Oncogene Whose Product can
be Targeted by All-Trans Retinoic Acid. Cancer Res 65: 919–924.
28. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, et al. (2005)
Global Gene Expression Profiling of Circulating Tumor Cells. Cancer Res 65:
4993–4997.
29. Park JC, Chae YK, Son CH, Kim MS, Lee J, et al. (2008) Epigenetic silencing of
human T (brachyury homologue) gene in non-small-cell lung cancer.
Biochemical and Biophysical Research Communications 365: 221–226.
30. Inamura K, Shimoji T, Ninomiya H, Hiramatsu M, Okui M, et al. (2007) A
metastatic signature in entire lung adenocarcinomas irrespective of morpholog-
ical heterogeneity. Human Pathology 38: 702–709.
31. R-Development-Core-Team (2005) R: A language and environment for
statistical computing. 3-900051-07-0 ed. Vienna, Austria: R Foundation for
Statistical Computing.
32. Efron B, Tibshirani RJ (1993) An introduction to the bootstrap; Cox DR,
Hinkley DV, editors. New York - London: Chapman & Hall. pp 1–436.
33. Royston P (1982) An Extension of Shapiro and Wilk’s W Test for Normality to
Large Samples. Applied Statistics 31: 115–124.
Cancer Transcriptomes
PLoS ONE | www.plosone.org 10 May 2010 | Volume 5 | Issue 5 | e10398